Using Regression Trees to Predict the Development of Immune-Mediated Adverse Events in Patients Receiving Immune Checkpoint Inhibitor Therapy. (2024). Voprosy Onkologii, 70(4), 677-684. https://doi.org/10.37469/0507-3758-2024-70-4-677-684